News | August 31, 2022
Hikma launches seasonal allergic rhinitis nasal spray RYALTRIS in the US
This launch builds upon Hikma’s leading position as one of the largest US providers of nasally administered medicines used for treating seasonal allergies and advances its objective of growing its specialty business in the US
